Placenta
Volume 28, Issue 11 , Pages 1099-1106, November 2007

Innate Immune Defences in the Human Uterus during Pregnancy

  • A.E. King

      Affiliations

    • Department of Physiology, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Centre for Reproductive Biology, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. Tel.: +44 (0)131 242 6613; fax: +44 (0)131 242 6441.
  • ,
  • R.W. Kelly

      Affiliations

    • MRC Human Reproductive Sciences Unit, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, UK
  • ,
  • J.-M. Sallenave

      Affiliations

    • Pr. Universite Denis Diderot-Paris 7/Institut Pasteur, Unite de Defense Innee et Inflammation, INSERM E336, Batiment Metchnikoff, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex, France
  • ,
  • A.D. Bocking

      Affiliations

    • Department of Physiology, University of Toronto, Toronto, Ontario, Canada
    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
  • ,
  • J.R.G. Challis

      Affiliations

    • Department of Physiology, University of Toronto, Toronto, Ontario, Canada
    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada

Accepted 8 June 2007. published online 03 August 2007.

Abstract 

The prevention of uterine infection is critical to appropriate fetal development and term delivery. The innate immune system is one component of the uterine environment and has a role in prevention of uterine infection. Natural antimicrobials are innate immune molecules with anti-bacterial, anti-viral and anti-fungal activity. We discuss two groups of natural antimicrobials in relation to pregnancy: (i) the defensins; and (ii) the whey acidic protein motif containing proteins, secretory leukocyte protease inhibitor (SLPI) and elafin. Human beta-defensins (HBD) 1–3 are expressed by placental and chorion trophoblast, amnion epithelium and decidua in term and preterm pregnancy. Elafin shows a similar pattern of localisation while SLPI is produced only by amnion epithelium and decidua. Evidence suggests that there is aberrant production of some natural antimicrobials in pathologic conditions of pregnancy. In preterm premature rupture of membranes (PPROM) levels of SLPI and elafin are reduced in amniotic fluid and fetal membranes, respectively. Elafin and HBD3 increase in chorioamnionitis and levels of the α-defensins, HNP1–3, increase in maternal plasma and amniotic fluid in women affected by microbial invasion of the uterus. In vitro culture studies have suggested a mechanism for increased production of natural antimicrobials in chorioamnionitis. Elafin, SLPI, HBD2 and 3 are all upregulated by inflammatory molecules in cells derived from gestational tissues. In summary, production of natural antimicrobials at key sites within the pregnant uterus suggests an important role in prevention of uterine infection during pregnancy and labour. Aberrant production of these molecules in PPROM and chorioamnionitis suggests that they also have a role in pathologic conditions. In particular, upregulation of these molecules by inflammatory molecules present in chorioamnionitis will ensure a robust response to infection.

Keywords: Pregnancy, Placenta, Fetal membranes, Innate immunity, Defensins, SLPI, Elafin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4004(07)00145-2

doi:10.1016/j.placenta.2007.06.002

Placenta
Volume 28, Issue 11 , Pages 1099-1106, November 2007